Novelion Therapeutics Inc. buy melinda
Start price
06.11.17
/
50%
?4.39
Target price
06.12.17
€6.31
Performance (%)
-31.21%
End price
06.12.17
€3.02
Summary
This prediction ended on 06.12.17 with a price of €3.02. Massive losses of -31.21% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novelion Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -3.429% | 3.133% | 15.455% | 14.827% |
| iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% | 27.167% |
| iShares Nikkei 225® | -7.364% | 1.018% | 8.293% | -2.680% |
| iShares S&P 500 | -4.366% | 0.247% | 18.541% | 32.687% |
Comments by melinda for this prediction
In the thread Novelion Therapeutics Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Novelion Therapeutics, Inc. entwickelt und vermarktet Augen products.It für Einzelpersonen bei der Entwicklung neuer Standards der Pflege beschäftigt ist mit einem seltenen Erkrankungen.Verwendung Unternehmen leben hat seinen Hauptsitz in Vancouver, Kanada
(Vom Mitglied beendet)
Stopped prediction by melinda for Novelion Therapeutics Inc.
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?0.83
27.05.19
27.05.19
€1.17
15.11.19
15.11.19
0.00%
15.11.19
15.11.19
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?0.95
14.10.18
14.10.18
€1.80
07.11.18
07.11.18
-32.36%
07.11.18
07.11.18
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?8.40
13.05.17
13.05.17
€9.92
22.06.17
22.06.17
5.32%
22.06.17
22.06.17
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?18.89
06.12.13
06.12.13
€17.14
06.06.14
06.06.14
0.00%
06.06.14
06.06.14